Overview

A Study to Compare Safety and Efficacy of Osmotic Release Oral Syytem (OROS) Hydromorphone Hydrochloride (HCl) With Morphine Sustain Release (SR) in Participants With Cancer Pain

Status:
Terminated

Trial end date:
2008-12-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the effectiveness and safety of Osmotic Release Oral System (OROS) hydromorohone Hydrochloride (HCl) compared with morphine sustain release (SR) in participants with chronic (lasting a long time) malignant (cancerous) cancer pain.

Phase:

Phase 3

Details

Lead Sponsor:

Johnson & Johnson Taiwan Ltd

Treatments:

Hydromorphone
Morphine
Sulfamethazine